<SUBMISSION>
<ACCESSION-NUMBER>0000947871-03-002320
<TYPE>6-K
<PUBLIC-DOCUMENT-COUNT>2
<PERIOD>20031027
<FILING-DATE>20031027
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>BUNGE LTD
<CIK>0001144519
<ASSIGNED-SIC>2070
<IRS-NUMBER>000000000
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>6-K
<ACT>34
<FILE-NUMBER>001-16625
<FILM-NUMBER>03958543
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>50 MAIN STREET
<CITY>WHITE PLAINS
<STATE>NY
<ZIP>10606
<PHONE>9146842800
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>50 MAIN STREET
<CITY>WHITE PLAINS
<STATE>NY
<ZIP>10606
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>f6k_102703.txt
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
                                    FORM 6-K

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                        Report of Foreign Private Issuer

                      Pursuant to Rule 13a-16 or 15d-16 of
                       the Securities Exchange Act of 1934


                                October 27, 2003

                        Commission File Number 001-16625



                                  BUNGE LIMITED

                 (Translation of registrant's name into English)

                                 50 Main Street
                          White Plains, New York 10606
                    (Address of principal executive offices)

         Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:

                           Form 20-F ___X___Form 40-F______

         Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1):

         Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7):

         Indicate by check mark whether by furnishing the information contained
in this Form the registrant is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

                           Yes ________              No ___X_____

         If "Yes" is marked, indicate below the file number assigned to the
registrant with Rule 12g3-2(b): 82-


<PAGE>







This report on Form 6-K shall be incorporated by reference into the Registration
Statements on Form F-3 (Registration Nos. 333-104974, 333-106182, 333-107376 and
333-108441), as amended, and the Registration Statement on Form F-4
(Registration Statement No. 333-108462), as amended, filed by Bunge Limited
Finance Corp. and Bunge Limited under the Securities Act of 1933, as amended,
and the Registration Statements on Form S-8 (Registration Nos. 333-66594,
333-75762, 333-76938 and 333-109446) filed by Bunge Limited under the Securities
Act of 1933, to the extent not superseded by documents or reports subsequently
filed under the Securities Act of 1933 or the Securities Exchange Act of 1934,
as amended.


<PAGE>


                                  EXHIBIT INDEX

Exhibit 1   Press release, dated October 24, 2003, announcing acquisition of
            shares of Fosfertil.


<PAGE>







                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                                   BUNGE LIMITED





Date: October 27, 2003                             By:   /s/ William M. Wells
                                                        ------------------------
                                                         William M. Wells
                                                         Chief Financial Officer



</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>3
<FILENAME>ex1_102703.txt
<DESCRIPTION>PRESS RELEASE DATED OCTOBER 24, 2003
<TEXT>
                                                                       Exhibit 1

                                              Contact:   Susie Ter-Jung
                                                         Bunge Limited
                                                         1-914-684-3398
                                                         susieter-jung@bunge.com

           Bunge Limited Announces Acquisition of Shares of Fosfertil

WHITE PLAINS, NY - October 24, 2003 - Bunge Limited (NYSE: BG) today announced
that its Brazilian fertilizer subsidiary, Bunge Fertilizantes S.A., has acquired
from Companhia Vale do Rio Doce (CVRD) 10.96% of the voting shares and 11.19% of
the non-voting shares, representing in the aggregate 11.12% of the total
outstanding share capital, of Fertilizantes Fosfatados S.A. (Fosfertil). As a
result of the acquisition, Bunge Fertilizantes now owns 11% of the voting shares
and over 12% of the total outstanding share capital of Fosfertil. Bunge
Fertilizantes also owns approximately 52% of Fertifos, a holding company that
owns 82% of the voting shares and approximately 56% of the total outstanding
share capital of Fosfertil. The total purchase price for the shares paid to CVRD
was R$240 million (approximately $84 million). Bunge Limited does not believe
that the acquisition will have a dilutive impact on its earnings per share.

About Bunge

Bunge Limited (www.bunge.com) is an integrated, global agribusiness and food
company operating in the farm-to-consumer food chain with worldwide distribution
capabilities and primary operations in North America, South America and Europe.
Founded in 1818 and headquartered in White Plains, New York, Bunge has 24,000
employees and locations in 29 countries. Bunge is the world's leading oilseed
processing company, the largest producer and supplier of fertilizers to farmers
in South America and the world's leading seller of bottled vegetable oils to
consumers.

About Fosfertil

Fosfertil operates three of six major phosphate mines in Brazil, and is Brazil's
largest producer of phosphate and nitrogen fertilizers. With
vertically-integrated production and strategically-located operating assets,
Fosfertil competitively supplies the rapidly growing fertilizer market in
Brazil.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains both historical and forward-looking statements. All
statements, other than statements of historical fact are, or may be deemed to
be, forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended. These forward-looking statements are not based on
historical facts, but rather reflect our current expectations and projections
about our future results, performance, prospects and opportunities. We have
tried to identify these forward-looking statements by using words including
"may," "will," "expect," "anticipate," "believe," "intend," "estimate" and
"continue" and similar expressions. These forward-looking statements involve
known and unknown risks, uncertainties and other factors that could cause our
actual results, performance, prospects or opportunities to differ materially

<PAGE>

from those expressed in, or implied by, these forward-looking statements. The
following important factors, among others, could affect our business and
financial performance: our ability to complete, integrate and benefit from
acquisitions, divestitures, joint ventures and alliances; estimated demand for
commodities and other products that we sell and use in our business; industry
conditions, including the cyclicality of the agribusiness industry; economic and
political conditions in the primary markets where we operate; and other
economic, business, competitive and/or regulatory factors affecting our business
generally. The forward-looking statements included in this release are made only
as of the date of this release, and except as otherwise required by federal
securities law, we do not have any obligation to publicly update or revise any
forward-looking statements to reflect subsequent events or circumstances.

</TEXT>
</DOCUMENT>
</SUBMISSION>
